A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma

Aim: Low grade glioma (LGG) is a lethal brain cancer with relatively poor prognosis in young adults. Thus, this study was performed to develop novel molecular biomarkers to effectively predict the prognosis of LGG patients and finally guide treatment decisions. Methods: survival-related genes were d...

Full description

Bibliographic Details
Main Authors: Wentao Liu, Jiaxuan Zou, Rijun Ren, Jingping Liu, Gentang Zhang, Maokai Wang
Format: Article
Language:English
Published: SAGE Publishing 2021-02-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033821992084
id doaj-308382a9d59341a8a10490942c3847f8
record_format Article
spelling doaj-308382a9d59341a8a10490942c3847f82021-02-09T17:03:48ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-02-012010.1177/1533033821992084A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade GliomaWentao Liu0Jiaxuan Zou1Rijun Ren2Jingping Liu3Gentang Zhang4Maokai Wang5 Department of Neurosurgery, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong Province, China Fuzhou Medical College of Nanchang University, Nanchang, Jiangxi Province, China Department of Neurosurgery, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong Province, China Department of Neurosurgery, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong Province, China Department of Neurosurgery, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong Province, China Department of Neurosurgery, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong Province, ChinaAim: Low grade glioma (LGG) is a lethal brain cancer with relatively poor prognosis in young adults. Thus, this study was performed to develop novel molecular biomarkers to effectively predict the prognosis of LGG patients and finally guide treatment decisions. Methods: survival-related genes were determined by Kaplan-Meier survival analysis and multivariate Cox regression analysis using the expression and clinical data of 506 LGG patients from The Cancer Genome Atlas (TCGA) database and independently validated in a Chinese Glioma Genome Atlas (CGGA) dataset. A prognostic risk score was established based on a linear combination of 10 gene expression levels using the regression coefficients of the multivariate Cox regression models. GSEA was performed to analyze the altered signaling pathways between the high and low risk groups stratified by median risk score. Results: We identified a total of 1489 genes significantly correlated with patients’ prognosis in LGG. The top 5 protective genes were DISP2, CKMT1B, AQP7, GPR162 and CHGB , the top 5 risk genes were SP1, EYA3, ZSCAN20, ITPRIPL1 and ZNF217 in LGG. The risk score was predictive of poor overall survival and relapse-free survival in LGG patients. Pathways of small cell lung cancer, pathways in cancer, chronic myeloid leukemia, colorectal cancer were the top 4 most enriched pathways in the high risk group. SP1, EYA3, ZSCAN20, ITPRIPL1, ZNF217 and GPR162 were significantly up-regulated, while DISP2, CKMT1B, AQP7 were down-regulated in 523 LGG tissues as compared to 1141 normal brain controls. Conclusions: The 10-gene signature may become novel prognostic and diagnostic biomarkers to considerably improve the prognostic prediction in LGG.https://doi.org/10.1177/1533033821992084
collection DOAJ
language English
format Article
sources DOAJ
author Wentao Liu
Jiaxuan Zou
Rijun Ren
Jingping Liu
Gentang Zhang
Maokai Wang
spellingShingle Wentao Liu
Jiaxuan Zou
Rijun Ren
Jingping Liu
Gentang Zhang
Maokai Wang
A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
Technology in Cancer Research & Treatment
author_facet Wentao Liu
Jiaxuan Zou
Rijun Ren
Jingping Liu
Gentang Zhang
Maokai Wang
author_sort Wentao Liu
title A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
title_short A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
title_full A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
title_fullStr A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
title_full_unstemmed A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
title_sort novel 10-gene signature predicts poor prognosis in low grade glioma
publisher SAGE Publishing
series Technology in Cancer Research & Treatment
issn 1533-0338
publishDate 2021-02-01
description Aim: Low grade glioma (LGG) is a lethal brain cancer with relatively poor prognosis in young adults. Thus, this study was performed to develop novel molecular biomarkers to effectively predict the prognosis of LGG patients and finally guide treatment decisions. Methods: survival-related genes were determined by Kaplan-Meier survival analysis and multivariate Cox regression analysis using the expression and clinical data of 506 LGG patients from The Cancer Genome Atlas (TCGA) database and independently validated in a Chinese Glioma Genome Atlas (CGGA) dataset. A prognostic risk score was established based on a linear combination of 10 gene expression levels using the regression coefficients of the multivariate Cox regression models. GSEA was performed to analyze the altered signaling pathways between the high and low risk groups stratified by median risk score. Results: We identified a total of 1489 genes significantly correlated with patients’ prognosis in LGG. The top 5 protective genes were DISP2, CKMT1B, AQP7, GPR162 and CHGB , the top 5 risk genes were SP1, EYA3, ZSCAN20, ITPRIPL1 and ZNF217 in LGG. The risk score was predictive of poor overall survival and relapse-free survival in LGG patients. Pathways of small cell lung cancer, pathways in cancer, chronic myeloid leukemia, colorectal cancer were the top 4 most enriched pathways in the high risk group. SP1, EYA3, ZSCAN20, ITPRIPL1, ZNF217 and GPR162 were significantly up-regulated, while DISP2, CKMT1B, AQP7 were down-regulated in 523 LGG tissues as compared to 1141 normal brain controls. Conclusions: The 10-gene signature may become novel prognostic and diagnostic biomarkers to considerably improve the prognostic prediction in LGG.
url https://doi.org/10.1177/1533033821992084
work_keys_str_mv AT wentaoliu anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT jiaxuanzou anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT rijunren anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT jingpingliu anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT gentangzhang anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT maokaiwang anovel10genesignaturepredictspoorprognosisinlowgradeglioma
AT wentaoliu novel10genesignaturepredictspoorprognosisinlowgradeglioma
AT jiaxuanzou novel10genesignaturepredictspoorprognosisinlowgradeglioma
AT rijunren novel10genesignaturepredictspoorprognosisinlowgradeglioma
AT jingpingliu novel10genesignaturepredictspoorprognosisinlowgradeglioma
AT gentangzhang novel10genesignaturepredictspoorprognosisinlowgradeglioma
AT maokaiwang novel10genesignaturepredictspoorprognosisinlowgradeglioma
_version_ 1724276430237335552